Shufeng Wu

Title: Shufeng Wu: Innovator in Pharmaceutical Compounds

Introduction

Shufeng Wu is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on crystalline sulfamide compounds. His research has implications for drug development and therapeutic applications.

Latest Patents

Shufeng Wu holds a patent for a crystalline sulfamide compound. The patent describes a crystalline (S)—N—((S)-1-(2-chlorphenyl)-2-((3,3-difluorocyclobutyl)amido)-2oxoethyl)-2-(4-cyanopyridin-2-base)-N-(3-fluorophenyl)-isothiazolidine-3-formamide 1,1-dioxide. This compound exhibits good IDH1 inhibitory activity and demonstrates high stability, making it valuable in terms of physical properties, safety, and metabolic stability.

Career Highlights

Throughout his career, Shufeng Wu has worked with prominent pharmaceutical companies, including Chia Tai Tianqing Pharmaceutical Group Co., Ltd. and Lianyungang Runzhong Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in drug formulation and development.

Collaborations

Shufeng Wu has collaborated with notable colleagues such as Xiquan Zhang and Wenwei Xu. These partnerships have facilitated advancements in his research and have enhanced the impact of his work in the pharmaceutical industry.

Conclusion

Shufeng Wu's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of new therapeutic compounds.